Skip to main content
Clinical Trials/DRKS00022845
DRKS00022845
Recruiting
N/A

eurological rehabilitation outcome of the treatment of patients with COVID-19 disease - NRO-COV-50

eurologische Klinik/ Station I2, Klinikum der Universität München0 sites500 target enrollmentSeptember 1, 2020
ConditionsG62.80G72.80

Overview

Phase
N/A
Intervention
Not specified
Conditions
G62.80
Sponsor
eurologische Klinik/ Station I2, Klinikum der Universität München
Enrollment
500
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
eurologische Klinik/ Station I2, Klinikum der Universität München

Eligibility Criteria

Inclusion Criteria

  • Age\> \= 18 years
  • COVID\-19 pathogen detection using PCR (not for control group)
  • COVID\-associated rehabilitation diagnosis (e.g. CIP / CIM, stroke, GBS, encephalopathy) For the non\-COVID\-19 CIP / CIM control group: Proven CIP / CIM as a qualifying NNFR diagnosis
  • Treatment from 1\.1\.2017 (i.b. for retrospective CIP / CIM control group)
  • Treatment in the NNFR for at least 48 hours
  • For a prospective sub\-project: Written consent to study participation after detailed information

Exclusion Criteria

  • For the prospective sub\-project: Refusal to participate in the study
  • Pregnant or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials